Personalized Medicine News and Research

RSS

University of Pittsburgh awarded NIH grant to lead Big Data to Knowledge Center of Excellence

The National Institutes of Health has awarded the University of Pittsburgh an $11 million, four-year grant to lead a Big Data to Knowledge Center of Excellence, an initiative that will help scientists capitalize more fully on large amounts of available data and to make data science a more prominent component of biomedical research.

10 Oct 2014

U-M scientists launch $11.5 million effort to better understand cause of Parkinson's disease

Deep in the brains of the million Americans with Parkinson's disease, changes to their brain cells put them at high risk of dangerous falls -- a problem that resists even the most modern treatments.

7 Oct 2014

CNIO researchers discover new specific marker for cancer stem cells

Tumours are mosaics of cells that are morphologically and molecularly very different. In this cellular heterogeneity, it is calculated that only 1-2% of the tumour mass is made up of cancer stem cells, which over the past years have been suggested to be responsible for the origin of cancer and for the resistance to conventional chemical therapies.

30 Sep 2014

Aptose joins Beat AML research collaboration

Aptose Biosciences Inc., a clinical-stage company developing new therapeutics and molecular diagnostics that target the underlying mechanisms of cancer, the Knight Cancer Institute at Oregon Health & Science University and The Leukemia & Lymphoma Society today announced that Aptose has joined the Beat AML collaboration.

29 Sep 2014

Early detection of cancers on the horizon with supersensitive nanodevice

Extremely early detection of cancers and other diseases is on the horizon with a supersensitive nanodevice being developed at The University of Alabama in Huntsville in collaboration with The Joint School of Nanoscience and Nanoengineering in Greensboro, NC.

29 Sep 2014

Crizotinib drug effectively halts growth of ROS1-positive lung tumors

Treatment with the targeted therapy drug crizotinib effectively halts the growth of lung tumors driven by rearrangements of the ROS1 gene. In an article receiving Online First publication in the New England Journal of Medicine to coincide with a presentation at the European Society for Medical Oncology meeting, an international research team reports that crizotinib treatment led to significant tumor shrinkage in 36 of 50 study participants and suppressed tumor growth in another 9.

29 Sep 2014

Cedars-Sinai to participate in a consortium studying motor neuron disorders

Investigators at the Cedars-Sinai Board of Governors Regenerative Medicine Institute have received a grant from the National Institutes of Health to participate in a consortium taking the study of motor neuron disorders - such as Lou Gehrig's disease and spinal muscular atrophy - to a new, comprehensive perspective.

26 Sep 2014

Eutropics inks NCI contract to develop Praedicare Dx platform technology for AML treatments

EUTROPICS Inc., a privately held company developing novel diagnostic tests, today announced that it has signed a contract with the National Cancer Institute through the Small Business Initiative Research (NCI-SBIR) program to develop its' Praedicare Dx platform for personalized medicine approaches in Acute Myeloid Leukemia (AML) patient management.

24 Sep 2014

XenOPAT aims to advance development of new drugs against cancer, personalized cancer treatments

On September 8th, the company XenOPAT SL, a spin-off of the Institute of Biomedical Research and the Catalan Institute of Oncology was established with the aim of bringing the company the latest scientific developments to the service combating cancer with two main branches: the development of new drugs and advance the implementation of personalized cancer treatments.

24 Sep 2014

High-throughput ChIP analysis platform introduced in new technical article

Porvair Sciences, in conjunction with researchers at Swansea University (UK) have written a new technical article entitled 'Chromatrap® 96: a new solid-state platform for high-throughput Chromatin Immunoprecipitation (ChIP)'.

From Chromatrap® - Porvair Sciences Ltd 24 Sep 2014

DNA sequencing may lead to greater care for patients with ventilator-associated pneumonia

A patient survives life-threatening trauma, is intubated in the intensive care unit (ICU) to support his or her affected vital functions, starts to recover, and then develops pneumonia.

23 Sep 2014

Scientists develop first blood test to diagnose major adult depression

The first blood test to diagnose major depression in adults has been developed by Northwestern Medicine- scientists, a breakthrough approach that provides the first objective, scientific diagnosis for depression.

18 Sep 2014

Researchers discover new details of how autoantibodies destroy healthy cells in skin

University at Buffalo researchers and colleagues studying a rare, blistering disease have discovered new details of how autoantibodies destroy healthy cells in skin.

11 Sep 2014

Dell, Terascala and TGen to install genomic data management solution at NCI

Dell, Terascala and the Translational Genomics Research Institute are installing state-of-the-art computing and programing specialized for human genome investigations at the National Cancer Institute.

10 Sep 2014

Stages of symptoms in schizophrenia: an interview with Dr. Mark Opler, ProPhase

I think there's a perception that schizophrenia is principally a disorder that involves hallucinations such as hearing voices, seeing things and believing things that aren't real. These are indeed part of the phenomenon, but the condition is much broader than that.

9 Sep 2014

Personalized Medicine News and Research

University of Pittsburgh awarded NIH grant to lead Big Data to Knowledge Center of Excellence

U-M scientists launch $11.5 million effort to better understand cause of Parkinson's disease

CNIO researchers discover new specific marker for cancer stem cells

Aptose joins Beat AML research collaboration

Early detection of cancers on the horizon with supersensitive nanodevice

Crizotinib drug effectively halts growth of ROS1-positive lung tumors

Cedars-Sinai to participate in a consortium studying motor neuron disorders

Eutropics inks NCI contract to develop Praedicare Dx platform technology for AML treatments

XenOPAT aims to advance development of new drugs against cancer, personalized cancer treatments

High-throughput ChIP analysis platform introduced in new technical article

DNA sequencing may lead to greater care for patients with ventilator-associated pneumonia

Scientists develop first blood test to diagnose major adult depression

Researchers discover new details of how autoantibodies destroy healthy cells in skin

Dell, Terascala and TGen to install genomic data management solution at NCI

Stages of symptoms in schizophrenia: an interview with Dr. Mark Opler, ProPhase

Researchers successfully evaluate new antibody-based drug for patients with severe asthma

Researchers develop new integrated approach to pinpoint genetic "drivers" of cancer

Researchers find that nanopores in material MoS2 could sequence DNA more accurately

Epigenetics has a large say in blood formation

Feist-Weiller, Caris Life Sciences partner to offer breakthrough technology to cancer patients

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News